Correlation Between Merck and Astellas Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and Astellas Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Astellas Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Co and Astellas Pharma, you can compare the effects of market volatilities on Merck and Astellas Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Astellas Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Astellas Pharma.

Diversification Opportunities for Merck and Astellas Pharma

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Merck and Astellas is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Merck Co and Astellas Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Astellas Pharma and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Co are associated (or correlated) with Astellas Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Astellas Pharma has no effect on the direction of Merck i.e., Merck and Astellas Pharma go up and down completely randomly.

Pair Corralation between Merck and Astellas Pharma

Assuming the 90 days horizon Merck Co is expected to generate 0.64 times more return on investment than Astellas Pharma. However, Merck Co is 1.56 times less risky than Astellas Pharma. It trades about -0.05 of its potential returns per unit of risk. Astellas Pharma is currently generating about -0.11 per unit of risk. If you would invest  10,324  in Merck Co on September 12, 2024 and sell it today you would lose (464.00) from holding Merck Co or give up 4.49% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Merck Co  vs.  Astellas Pharma

 Performance 
       Timeline  
Merck 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Merck is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Astellas Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Astellas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Merck and Astellas Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and Astellas Pharma

The main advantage of trading using opposite Merck and Astellas Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Astellas Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Astellas Pharma will offset losses from the drop in Astellas Pharma's long position.
The idea behind Merck Co and Astellas Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum